Does metformin sensitize endometrial cancer cells to chemotherapy by repressing glyoxalase I expression?
Metformin enhances the rate of cell-killing induced by chemotherapeutic agents by repressing GloI expression.
Patients submitted to MVR for rheumatic mitral valve disease have a poor prognosis, independently of having the subvalvular apparatus preserved. PSVA did not improve late survival in this setting.